|
Imatinib (Gleevec, Novartis Pharmaceuticals Corp, East Hanover, NJ) is
widely used in the treatment of chronic myelogenous leukemia and
gastrointestinal stromal tumors. To our knowledge, only one case report of
histologically proven Imatinib-induced hepatotoxicity has been reported. We
describe another case of hepatotoxicity in a 22-year-old woman including the
histopathologic changes and the clinical course after the discontinuation of
Imatinib.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
